Abstract:OBJECTIVE:To analyze the significance of various abnormal signal patterns appreared in CML and B-ALL patients by using BCR/ABL/ASS1 tricolor dual-fusion probe, and to explore its application value in detecting BCR/ABL fusion gene and ASS1 gene deletion.METHODS:50 newly diagnosed CML patients and 50 newly diagnosed B-ALL patients were detected by fluorescence in situ hybridization (FISH) with BCR/ABL/ASS1 tricolor dual-fusion probe. Meanwhile, karyotype analysis was performed on all the patients using the 24 hours short-term culture and R-banding.RESULTS:Among the 50 CML patients, Ph+ was found in 49 cases, 5 normal interphase karyotype was observed in 1 case. FISH detection showed that BCR/ABL fusion gene existed in all patients (100%), while the positive signal pathway showed that 1R1G2B2F was observed in 39 cases (78%), 2R1G2B1F in 2 cases (4%) and 1R1G2B1F in 6 cases (12%), simultaneous existence of 1R1G1B1F and 1R1G2B3F in 1 case (2%), 2R1G1B1F in 1 case (2%) 1R1G3B3F in 1 case (2%). FISH detection also showed that the karyotype of 6 case at ASS1 gene deletion (1R1G1B1F) all were simple t (9; 22) translocation, and other abnormalities not were observed. Among 50 cases of B-ALL, Ph+ was found in 13 cases, the numerical aberration and structural aberration of non t (9; 22) in 16 cases, normal karyotype in 20 cases, absence of mitotic phase in 1 case. FISH detection showed that 16 cases (32%) had BCR/ABL fusion gene including 13 cases (26%) of 1R1G2B2F, 1 case (2%) of stimultaneous exitance of 1R1G2B2F and 1R1G3B3F 1 case (2%) of 2R1G1B1F, 1 case (2%) of 1R1G3B2F. FISH detection also showed that 3 cases had BCR/ABL fusion gene, including 1 case with ASS1 gene deletion (2R1G1B1F), 1 case with classical t (9; 22) translocation (1R1G2B2F) and 1 case with BCR/ABL fusion gene and increase of ASS1 gene copy (1R1G3B3F).CONCLUSION:Tricolor dual-fusion FISH probe for detecting BCR/ABL fusion gene and ASS1 gene deletion is simple, rapid, sensitive and stable. It can detect various forms of molecular fusion and avoid the false positive results due to coincidental overlap of signals generated by D-FISH probe and ES-FISH probe. In addition, this detection method not only can directly observe the presence or absence of ASS1 gene deletion, but also improve the reliability of the positive results of newly diagnosed BCR/ABL fusion gene and accuracy of monitoring results of minimal residual disease for the subsequent visit.

Detection of the Tumor Load in Chronic Myeloid Leukemia During Treatment with Interferon(ifn)by Conventional Cytogenetics,nested-Rt-pcr and FISH

[Detection of Tumor Load in Chronic Myeloid Leukemia During Treatment with Transplantation by Conventional Cytogenetics, Nested-Rt-pcr and FISH].

Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia

[Monitoring of the Therapeutic Response of Interferon to Chronic Myeloid Leukemia by Duel-Color Fluorescence in Situ Hybridization].

[Comparative Study of Cytogenetic Response Evaluated by Conventional Banding Analysis and Fluorescence in Situ Hybridization in Chronic Myeloid Leukemia Patients During Tyrosine Kinase Inhibitor Treatment].

[Clinical application of BCR/ABL probes in myeloproliferative disorders].

Study on the cases with BCR/ABL fusion gene positively detected by fluorescence in situ hybridization

Detection of Bcr-Abl Fusion Gene in Ph- Bcr-Abl+ Hematological Disorders by Fluorescence in Situ Hybridization

Clinical value of interphase fluorescent in situ hybridization in diagnosis of core-binding factor acute myelocytic leukemia]

Advantages of Digital PCR in the Detection of Low Abundance BCR-ABL1 Gene in Patients with Chronic Myeloid Leukemia

Quantitative detection of BCR–ABL fusion gene and its application in monitoring chronic myeloid leukemia treatment

Application Of Dual Fusion Interphase Fluorescence In Situ Hybridization Probe To The Detection Of Minimal Residual Disease In Chronic Myeloid Leukemia

[Detection of Bcr/abl Fusion Gene by Dual Color-Dual Fusion Fluorescence in Situ Hybridization].

Application of Dual-Color Fluorescence in Situ Hybridization in Acute Myeloid Leukemia with T(8;21)

Real-time Quantitative PCR Monitoring of Minimal Residual Disease in CML after Treatment

Detection of ATM and RB1 Deletion in Chronic Lymphocytic Leukemia by Fluorescence In Situ Hybridization

[Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].

Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals

[Detection of BCR/ABL Fusion Gene and ASS1 Gene Deletion by Using Tricolor Dual-fusion Probe].

[Monitoring Bcr/abl Mrna Levels in Imatinib Mesylate Treated Chronic Myeloid Leukemia Patients by Real-Time Quantitative RT-PCR].

[Analysis of Cytogenetic Response in Ph+ Chronic Myeloid Leukemia Patients Treated with Interferon Alpha].